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Strengths and limitations of this study
 ► This randomised controlled trial will investigate a 
simple, inexpensive way of supporting patients with 
low back pain.
 ► The study team and the participants are blinded to 
the intervention in each of the groups.
 ► Restriction to participants being discharged from a 
course of therapy and speaking English may limit 
the generalisability of the findings.
AbStrACt
Introduction The Pain Toolkit is a self- management 
tool for people with persistent pain. It is available for use 
worldwide in multiple formats. To date, no studies have 
investigated the effectiveness of this intervention. This 
study aims to investigate the effectiveness of the Pain 
Toolkit in comparison with a simple education control for 
people with low back pain.
Methods and analysis Participants who have been 
discharged from the North of England Regional Back Pain 
Pathway will be randomised using sealed, consecutively 
numbered opaque envelopes to receive either the Pain 
Toolkit and the Back Book (intervention group) or the 
Back Book only (control group). Both the therapist and the 
participant will be blind to group allocation. The primary 
outcome measure will be disability (Oswestry Disability 
Index (ODI)). Secondary outcome measures will be pain (0–
10 numerical scale), healthcare use (number of healthcare 
professional visits) and quality of life (EuroQol- 5D). 
Outcome measures will be completed at baseline and at 
6 and 12 months. Data will be analysed using analysis of 
covariance, adjusting for baseline values. A change of 10 
points in the ODI will be considered a clinically important 
change. Additionally, a subsample of participants from the 
intervention group will undergo semistructured interviews 
to explore individuals’ experience of the Pain Toolkit. 
Participants will be asked questions about the ease of use 
and acceptability of the Pain Toolkit and also for how long 
they used the Toolkit. The qualitative data will be analysed 
using thematic analysis.
Ethics and dissemination Approval for the study was 
given by the Health Research Authority and the North East 
Newcastle, North Tyneside 2 Regional Ethics Committee 
(reference 18/NE/0144) and Teesside University (reference 
176/17). Findings will be disseminated through peer- 
reviewed journals and presentation at relevant patient 
groups, and local, national and international conferences.
trial registration number NCT03791164; Pre -results.
IntroduCtIon
Low back pain (LBP) is the leading cause of 
disability- adjusted life years worldwide.1–3 This 
causes a significant burden on health services, 
with 14% of primary care consultations being 
for LBP.4 Annual healthcare costs for patients 
with LBP are double those of matched control 
patients without back pain.5 LBP accounts for a 
significant disease burden and loss in produc-
tivity among working people.3 6 Bevan estimates 
that in 2015, ‘the total cost of lost productivity 
attributable to musculoskeletal disorders 
among people of working age in the EU could 
be as high as 2% of gross domestic product’.7 
The WHO’s definition of LBP states that ‘in 
many instances, …., the cause is obscure, and 
only in a minority of cases does a direct link to 
some defined organic disease exist’.8 9
Across the North of England, there is a 
regional back pain pathway10 that provides a 
consistent approach to the management of 
patients based on the National Institute for 
Health and Care Excellence (NICE) guide-
lines for the management of LBP.6 Early 
evidence demonstrates positive outcomes 
for patients on this regional back pain 
pathway.11 12 Within these guidelines, many 
of the options relate to self- management.6 
Although self- management is an integral 
part of the North of England Regional 
Back Pain Pathway, no specific informa-
tion is given as to the preferred nature of 
the self- management advocated, and the 
Pain Toolkit and the Back Book are not 
specifically referenced.10 Self- management 
can be defined as ‘day to day tasks that an 
individual must undertake to control or 
reduce the impact of disease on physical 
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clinical effectiveness,14–17 self- management is a persua-
sive option for resource- limited services. However, 
there is little clarity on exactly what constitutes self- 
management within the Back Pain Pathway and which 
approaches are best.13 18 19
The Pain Toolkit20 is a self- management tool for 
people with persistent pain. It has been developed by 
a non- healthcare professional with long- standing back 
pain. The goal of the Pain Toolkit is to facilitate patients 
to self- manage their pain condition. The Pain Toolkit 
has been available for 17 years, is available in multiple 
countries and has been made available by national 
healthcare providers such as NHS Choices.21 The Pain 
Toolkit remains popular with healthcare professionals 
and patients; however, the effectiveness of this widely 
available tool has not yet been investigated. The aim of 
this study is to investigate the effectiveness of the Pain 
Toolkit as a self- management tool for people with back 
pain following discharge from a treatment pathway. 
The outcome of the study may help to support a recom-
mendation to the North of England Regional Back Pain 




The primary objective of the study is to investigate the 
effectiveness of the Pain Toolkit for disability as measured 
by the Oswestry Disability Index (ODI) for people with 
LBP who have been discharged from a treatment pathway 
in comparison with a usual care control.
Secondary objectives
The secondary objectives of this study are as follows:
To investigate the effectiveness of the Pain Toolkit 
for pain as measured by a numerical pain rating scale 
(NRS) for people with LBP who have been discharged 
from a treatment pathway in comparison with a usual 
care control.
To investigate the effectiveness of the Pain Toolkit for 
healthcare use as measured by reported healthcare 
professional visit numbers for people with LBP who 
have been discharged from a treatment pathway in 
comparison with a usual care control.
To investigate the effectiveness of the Pain Toolkit for 
quality of life as measured by EuroQol- 5D (EQ5D) 
for people with LBP who have been discharged from 
a treatment pathway in comparison with a usual care 
control.
To explore participants’ experiences of using the Pain 
Toolkit.
MEthodS And AnAlySIS
description of the study
This will be a mixed- methods, double- blind, randomised 
controlled trial.
Patient and public involvement
In developing the ideas for this study, the author met with 
the Patient Reference Group of the North Durham Clin-
ical Commissioning Group. This is a group of patients and 
members of the public registered with general practices 
in the North Durham area. Patients were not involved 
in recruitment for the study. Patients were shown copies 
of the Pain Toolkit and the Back Book and were asked 
about their opinions on the usefulness of the informa-
tion contained and the ease of understanding of the 
materials. They gave opinions on the time at which the 
information would be useful within the care pathway and 
whether people with learning disabilities would be able 
to access support to use the materials. This information 
was used to shape the timing of the intervention within 
the pathway. They concluded that the self- management 
approach should be promoted and that the use of the 
self- management tools did not appear to be overburden-
some. Results of the study will be fedback to this group 
and other patient groups once the study has concluded.
Sample selection
Setting
Participants will be a convenience sample of patients with 
LBP who have been discharged from the North of England 
Regional Back Pain Pathway. The North of England 
Regional Back Pain Pathway is an evidence- based pathway 
of care for people with back pain that operationalises 
the NICE guidelines.6 Participants will be approached to 
participate in the study at the point of discharge from the 
pathway by their healthcare practitioner.
Participants
We will include individuals with pain in the lower back 
of any duration that is not associated with any serious 
disease or potentially serious condition in keeping with 
the NICE guidelines.6 Individuals will be eligible for the 
study if they are over 18 years of age, have recently been 
discharged/are in the process of being discharged from 
the North of England Regional Back Pain Pathway, and 
are fluent in written and spoken English. Individuals will 
be excluded if they present with red flag indicators indic-
ative of the need for onward referral for medical investi-
gation6 or if they are unable to provide informed consent 
to participate in the study.
Recruitment
At the point of discharge from the North of England 
Regional Back Pain Pathway, clinicians will give potential 
participants a brief overview of the study and will ask if 
they are willing to have a member of the research team 
contact them. The research team will contact potential 
participants and will explain the study in detail. If the 
individual meets the inclusion/exclusion criteria and 
is willing to participate, a baseline questionnaire and 
consent form will then be posted to the participant. Addi-
tional recruiting sites will be added to the study until the 
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Randomisation
On receipt of the completed consent form and base-
line questionnaire in the post from the participant, the 
research team will randomise the participant to either the 
intervention or the control group using sealed, opaque, 
sequentially numbered envelopes. The randomisation 
order will be generated by an online random number 
generator22 by a member of the research team not 
involved in the recruitment process. The participant will 
be posted the appropriate material dependent on group 
allocation.
Interventions
The intervention group will receive the Pain Toolkit, 
which is a self- management advice tool. The Pain Toolkit 
is widely available in paper and electronic format in 
English and other formats. For the purposes of this study, 
a paper version will be used. The Pain Toolkit gives 12 
options for managing pain, covering topics such as accep-
tance, goal setting, relaxation, exercise and pacing.23 The 
reader is encouraged to choose up to 3 of the 12 options 
and to use them until they feel confident in using the 
intervention, and then to choose a 3 further options and 
repeat the process. Using all 12 options is not essential 
but is encouraged. While using the Pain Toolkit, patients 
are encouraged to see pain as a chronic condition over 
which they need to take control. Self- management as an 
active form of pain management is encouraged, rather 
than passive expectations that healthcare professionals 
will address the patient’s pain. In preparation for the 
study, a group of patient representatives were asked to 
review and comment on the Pain Toolkit. While not part 
of the formal evaluation of the study, this preparatory 
work provided valuable insight into patients' percep-
tion of the Pain Toolkit. The patients present felt that 
the document was easy to understand, although people 
with learning disabilities may need some help to under-
stand it. They also felt that because the Pain Toolkit was 
a useful guide, it should be offered as early as possible 
into the pathway.
Control
The control group will receive a copy of the Back Book.24 
The Back Book is a guidance- based, patient information 
leaflet that aims to promote acceptance of back pain 
as an enduring feature and to encourage the patient 
to undertake light activity. It is one of the most widely 
used sources of patient information for patients with 
LBP.25 26 It has been reported that the Back Book has 
improved outcomes in patients who had a fear of phys-
ical activity.25 27
The intervention group will also receive a copy of the 
Back Book so that the only difference between the groups 
is the intervention of interest, that is, the Pain Toolkit. 
Both groups will be instructed to carry on with their usual 




The primary outcome measure for the study will be the 
ODI.28 The ODI is a measure of pain- related disability. The 
ODI, first published in 1980,28 is one of the most commonly 
used outcome measures used with people with LBP.29 The 
ODI has been shown to be a valid and reliable measure of 
pain- related disability.30 In 2006, an international expert 
panel determined that a change of 10 points (approxi-
mately 30% change) equates to a minimally important 
difference (MID)31; thus, for the purposes of this study, a 
10- point change in the ODI will be used as the MID.
Secondary outcome measures
A number of secondary outcome measures will also be 
used to investigate the effectiveness of the intervention. 
Pain intensity will be measured using an NRS, which is a 
validated outcome measure of pain.32 33
Healthcare usage will be measured using a self- 
reported number of contacts with a healthcare profes-
sional during the intervention period. It is reported that 
general health, including mental health, can impact on a 
patient’s perception of pain.34 It is therefore important to 
consider a patient’s overall quality of life. Quality of life 
will be measured using the EQ5D.35 EQ5D is an assess-
ment of health status and has been shown to correlate to 
the ODI and has the ability to identify clinically important 
changes.36 The EQ5D system has five domains: mobility, 
self- care, usual activities, pain/discomfort and anxiety/
depression. Participants answer questions in each of the 
areas, and this is reported as a single health status value.
At each follow- up point, participants are asked the extent 
to which they have used the intervention that they have 
received and whether there has been any change in their 
medication or therapy regime that may impact on their 
outcome measures. This information will be analysed by the 
research team as per the statistical analysis plan.
A subgroup of participants from the intervention group 
will be identified and purposively sampled by a member of 
the research team, which is otherwise uninvolved with the 
study so as not to interfere with the study blinding. The 
researcher will attempt to select participants with a range 
of backgrounds with regard to age, gender and duration 
of symptoms. The interviews will be audio- recorded and 
will last approximately 1 hour. This part of the study will 
assess how acceptable the interventions were to the partic-
ipants. The participants will be asked whether they found 
the tool helpful and easy to use. They will also be asked 
how much of the toolkit they have used and for how long 
to assess intervention fidelity. They will be asked whether 
they will continue to use the Pain Toolkit and whether 
they would recommend it to other patients.
data analysis plan
Blinding
Sequentially numbered, sealed, opaque envelopes 
containing the study intervention and control literature 
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team not involved in the recruitment or statistical analysis 
of the data. The randomisation list will be created by an 
online random number generator. The participants will be 
informed that they will be sent one (or two) of a number of 
leaflets to use to compare which one is most effective. They 
will not be aware which is the intervention leaflet and which 
is the control leaflet, nor will the therapist know which 
intervention they have been sent. Thus, both participants 
and researchers will be blinded to group allocation.
Sample size calculations
Using the NQuery software V.3 (Statistical Solutions, 
Cork, Ireland), we estimate that a sample size of 70 in 
each group will have 90% power to detect a mean differ-
ence of 10 points between the intervention and control 
groups, assuming that the common SD of change is 18 
points using a two- group t- test with a 0.050 two- sided 
significance level. The estimate of SD of change scores 
was obtained from previously collected data involving 
967 participants. Ultimately, the data will be analysed 
with a similar between- subjects model for comparison of 
change scores but with covariate adjustment for baseline 
measurements, age and sex. In total, 100 participants will 
be recruited to each group, which will allow for a 30% 
drop- out rate while retaining adequate statistical power.
The study will also record refusals, drop- outs and losses 
to follow- up. This may include participants who do not 
use the Pain Toolkit during the study period or who do 
not complete the outcome measures. It would potentially 
impact on the interpretation of the study results if either 
of these groups were large in number; it will therefore be 
important to determine how their results will be reported 
at the end of the study. There is no clear consensus on 
how missing data should be handled; however, we will 
complete an intention- to- treat analysis in which all partic-
ipants are analysed in the group to which they were origi-
nally randomised. The statistical analysis described below 
involves a linear mixed model using restricted maximum 
likelihood, which is a principled approach to addressing 
missing outcome data.
Statistical analysis
Data will be cleaned and checked for missing entries 
before any analysis begins. An IBM SPSS programme will 
be used for descriptive and inferential statistical analysis. 
Analysis will follow an intention- to- treat framework, using 
linear mixed models to compare outcomes between the 
two groups. Data will be analysed using a linear mixed anal-
ysis of covariance model, adjusting for chance imbalances 
in outcome between groups at baseline. There will also be 
analysis of the covariates collected, including age, gender 
and duration of symptoms. This will be conducted by a stat-
istician blinded to the group allocation. A 5% level of statis-
tical significance will be used throughout. The research 
team will be unblinded once the analysis is complete.
Qualitative data gathered as part of the semistructured 
interviews will be transcribed and analysed using prag-
matic, inductive analysis.37 Following familiarisation with 
the data, initial codes will be generated, and then the data 
will be searched for themes. Themes may relate to prev-
alence of a topic being mentioned or may be identified 
because of their importance in relation to the research 
question. The themes will then be reviewed and refined. 
A second reader within the research team will read all 
transcripts to enhance study credibility and that the 
themes are rooted in the data.
Ethical considerations
Ethical approval for the study has been given by the Health 
Research Authority and the North East Newcastle, North 
Tyneside 2 Regional Ethics Committee (reference 18/
NE/0144) and Teesside University’s School of Health and 
Social Care Research Ethics and Governance Committee 
(reference 176/17). Participation in the study is based 
on informed consent of individuals, and participants are 
informed that usual treatment will be maintained whether 
or not they wish to participant in the study.
dissemination
Dissemination of the findings will include presentations 
at relevant patient groups and at local, national and inter-
national conferences, and publication in peer- reviewed 
journals.
ConCluSIonS
This paper describes the protocol for a study to investi-
gate the effectiveness of a structured self- management 
programme (the Pain Toolkit) compared with standard 
treatments. This study will be of interest to all who work 
in the field of LBP, including service commissioners. The 
study should provide valuable information about the 
effectiveness of the Pain Toolkit in assisting patients after 
discharge from services.
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